Webinar

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Format: External webinar | Document type: Webinar

This content is provided by Recipharm AB, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Related categories: Analytical (technologies & services) Facilities

  • Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity.
  • Customizing the downstream process to address the different needs from supercoil plasmid and linear isoform.
  • A platform approach with integrated processes and analytical toolboxes to accelerate plasmid development to manufacturing.

Watch Now

Speaker

Jing Zhu Jing Zhu Vice President, Nucleic Acid & Viral Vector Technology
AAV Process Development

Related resources from Recipharm AB

Supplier info centre